November 15, 2004
India APIs May Lure US Drug Manufacturers
With the cost of drugs in the US rising, many Indian drug companies, especially the manufacturers of active pharmaceutical ingredients (APIs) expect that US drug companies will outsource.
According to the Financial Express:
Besides APIs, offshoring is set to increase due to the medical billing pattern prevalent in the US. While most companies invest heavily in innovative research and development (R&D), the cost of manufacturing in the US is also on the higher side, thus pushing up prices. In this regard, Indian companies see a bright future in offshoring for contract R&D and manufacturing generics, says Export-Import (Exim) Bank of India executive director S Sridhar.
Read more: Indian firms see outsourcing potential in US drug price hike
--
Did you enjoy this post?
Comments
The comments to this entry are closed.
« White Collar Outsourcing | Main | Outsourcing Benefits Everyone »
Copyright © 2005 Dotmarketer | All Rights Reserved.
Recent Comments